Ledger.Open graph →
SEC Form D · Amendment · filed August 18, 2020

Quellis Biosciences, Inc

Offering
$18.5M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Frederick Callori · Waltham, MADirectorJonathan Violin · Waltham, MAExec · DirectorChristopher Garabedian · Philadelphia, PADirectorValerie M. Bauer Gore · Columbus, OHDirectorJonathan Poma · Columbus, OHExec · DirectorVijay W. Palkar · New York, NYExec · DirectorLouise W. Smith · Richmond, VADirectorChristopher Garabedian · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗